{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:57:28Z","timestamp":1758776248519,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04334-4","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T02:48:05Z","timestamp":1751251685000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experience with apheretic treatment in the chronic management of severe hypertriglyceridemia: case series"],"prefix":"10.1007","volume":"90","author":[{"given":"Francesco","family":"Sbrana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Dal Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Corciulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Bigazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Sampietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"4334_CR1","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"H.N. Ginsberg, C.J. Packard, M.J. Chapman, J. Bor\u00e9n, C.A. Aguilar-Salinas, M. Averna, B.A. Ference, D. Gaudet, R.A. Hegele, S. Kersten, G.F. Lewis, A.H. Lichtenstein, P. Moulin, B.G. Nordestgaard, A.T. Remaley, B. Staels, E.S.G. Stroes, M.R. Taskinen, L.S. Tokg\u00f6zo\u011flu, A. Tybjaerg-Hansen, J.K. Stock, A.L. Catapano, Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur. Heart J. 42, 4791\u20134806 (2021).","journal-title":"Eur. Heart J."},{"key":"4334_CR2","unstructured":"J.D. Brunzell, S.S. Deeb, in The Metabolic and Molecular Bases of Inherited Disease, ed. by C.S.Scriver, A.L.Beaudet, W.S.Sly. (Mc Graw-Hill, New York, 2001). p. 2789\u201322816."},{"key":"4334_CR3","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1210\/js.2019-00214","volume":"3","author":"LSL O\u2019Dea","year":"2019","unstructured":"L.S.L. O\u2019Dea, J. MacDougall, V.J. Alexander, A. Digenio, B. Hubbard, M. Arca, P.M. Moriarty, J.J.P. Kastelein, E. Bruckert, H. Soran, J.L. Witztum, R.A. Hegele, D. Gaudet, Differentiating familial chylomicronemia syndrome from multifactorial severe hypertriglyceridemia by clinical profiles. J. Endocr. Soc. 3, 2397\u20132410 (2019).","journal-title":"J. Endocr. Soc."},{"key":"4334_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","volume":"8","author":"RA Hegele","year":"2020","unstructured":"R.A. Hegele, J. Bor\u00e9n, H.N. Ginsberg, M. Arca, M. Averna, C.J. Binder, L. Calabresi, M.J. Chapman, M. Cuchel, A. von Eckardstein, R. Frikke-Schmidt, D. Gaudet, G.K. Hovingh, F. Kronenberg, D. L\u00fctjohann, K.G. Parhofer, F.J. Raal, K.K. Ray, A.T. Remaley, J.K. Stock, E.S. Stroes, L. Tokg\u00f6zo\u011flu, A.L. Catapano, Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Lancet Diabetes Endocrinol. 8, 50\u201367 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4334_CR5","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1210\/clinem\/dgaa838","volume":"106","author":"M Belhassen","year":"2021","unstructured":"M. Belhassen, E. Van Ganse, M. Nolin, M. B\u00e9rard, H. Bada, E. Bruckert, M. Krempf, V. Rebours, R. Valero, P. Moulin, 10-year comparative follow-up of familial versus multifactorial chylomicronemia syndromes. J. Clin. Endocrinol. Metab. 106, e1332\u201342 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4334_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12020-020-02506-y","volume":"71","author":"AB Cefal\u00f9","year":"2021","unstructured":"A.B. Cefal\u00f9, A. Giammanco, D. Noto, R. Spina, D. Cabibi, C.M. Barbagallo, M. Averna, Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome. Endocrine 71, 344\u2013350 (2021).","journal-title":"Endocrine"},{"key":"4334_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMc2306575","volume":"390","author":"VJ Alexander","year":"2024","unstructured":"V.J. Alexander, E. Karwatowska-Prokopczuk, T.A. Prohaska, L. Li, R.S. Geary, I. Gouni-Berthold, E.A. Oral, R.A. Hegele, E.S.G. Stroes, J.L. Witztum, S. Tsimikas, Volanesorsen to prevent acute pancreatitis in hypertriglyceridemia. N. Engl. J. Med. 390, 476\u2013477 (2024).","journal-title":"N. Engl. J. Med."},{"key":"4334_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"L. Connelly-Smith, C.R. Alquist, N.A. Aqui, J.C. Hofmann, R. Klingel, O.A. Onwuemene, C.J. Patriquin, H.P. Pham, A.P. Sanchez, J. Schneiderman, V. Witt, N.D. Zantek, N.M. Dunbar, Guidelines on the use of therapeutic apheresis in clinical practice. J. Clin. Apher. 38, 77\u2013278 (2023).","journal-title":"J. Clin. Apher."},{"key":"4334_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.transci.2013.06.017","volume":"49","author":"F Sbrana","year":"2013","unstructured":"F. Sbrana, M. Puntoni, F. Bigazzi, M. Margelli, C. Petersen, M. Pianelli, R. Luciani, R. Bonini, M. Ferrari, T. Sampietro, Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: a case report. Transfus. Apher. Sci. 49, 323\u2013327 (2013).","journal-title":"Transfus. Apher. Sci."},{"key":"4334_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/clinchem\/27.5.731","volume":"27","author":"S McNeely","year":"1981","unstructured":"S. McNeely, K. Seatter, J. Yuhaniak, M.L. Kashyap, The 16-hour-standing test and lipoprotein electrophoresis compared for detection of chylomicrons in plasma. Clin. Chem. 27, 731\u2013732 (1981).","journal-title":"Clin. Chem."},{"key":"4334_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1210\/clinem\/dgae613","volume":"110","author":"CM Spagnuolo","year":"2025","unstructured":"C.M. Spagnuolo, J. Wang, A.D. McIntyre, B.A. Kennedy, R.A. Hegele, Comparison of patients with familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome. J. Clin. Endocrinol. Metab. 110, 1158\u20131165 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4334_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","volume":"275","author":"P Moulin","year":"2018","unstructured":"P. Moulin, R. Dufour, M. Averna, M. Arca, A.B. Cefal\u00f9, D. Noto, L. D\u2019Erasmo, A. Di Costanzo, C. Mar\u00e7ais, L.A. Alvarez-Sala Walther, M. Banach, J. Bor\u00e9n, R. Cramb, I. Gouni-Berthold, E. Hughes, C. Johnson, X. Pint\u00f3, \u017d Reiner, J.R. van Lennep, H. Soran, C. Stefanutti, E. Stroes, E. Bruckert, Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an \u201cFCS score. Atherosclerosis 275, 265\u2013272 (2018).","journal-title":"Atherosclerosis"},{"key":"4334_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1525-1594.2009.00810.x","volume":"33","author":"C Stefanutti","year":"2009","unstructured":"C. Stefanutti, S. Di Giacomo, A. Vivenzio, G. Labbadia, F. Mazza, G. D\u2019Alessandri, G. Russi, G. De Silvestro, P. Marson, Therapeutic plasma exchange in patients with severe hypertriglyceridemia: a multicenter study. Artif. Organs 33, 1096\u20131102 (2009).","journal-title":"Artif. Organs"},{"key":"4334_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.886266","volume":"9","author":"M Paquette","year":"2022","unstructured":"M. Paquette, S. Bernard, The evolving story of multifactorial chylomicronemia syndrome. Front. Cardiovasc. Med. 9, 886266 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"4334_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11883-020-00885-1","volume":"22","author":"A Gallo","year":"2020","unstructured":"A. Gallo, S. B\u00e9liard, L. D\u2019Erasmo, E. Bruckert, Familial chylomicronemia syndrome (FCS): recent data on diagnosis and treatment. Curr. Atheroscler. Rep. 22, 63 (2020).","journal-title":"Curr. Atheroscler. Rep."},{"key":"4334_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1526-0968.2001.00383.x","volume":"5","author":"W Samtleben","year":"2001","unstructured":"W. Samtleben, N. Mistry-Burchardi, B. Hartmann, A. Lennertz, T. Bosch, Therapeutic plasma exchange in the intensive care setting. Ther. Apher. 5, 351\u2013357 (2001).","journal-title":"Ther. Apher."},{"key":"4334_CR17","doi-asserted-by":"publisher","first-page":"e29689","DOI":"10.1097\/MD.0000000000029689","volume":"101","author":"L Han","year":"2022","unstructured":"L. Han, G. Qiang, L. Yang, R. Kou, Q. Li, M. Xin, R. Liu, Z. Zhang, Plasma exchange therapy for familial chylomicronemia syndrome in infant: a case report. Medicine 101, e29689 (2022).","journal-title":"Medicine"},{"key":"4334_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1744-9987.13716","volume":"26","author":"GR Thompson","year":"2022","unstructured":"G.R. Thompson, The scientific basis and future of lipoprotein apheresis. Ther. Apher. Dial. 26, 32\u201336 (2022).","journal-title":"Ther. Apher. Dial."},{"key":"4334_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12020-024-03742-2","volume":"85","author":"B Dal Pino","year":"2024","unstructured":"B. Dal Pino, F. Sbrana, \u201cEve is not Adam\u201d - differences in efficacy, safety and clinical outcomes with lipoprotein apheresis between sexes. Endocrine 85, 233\u2013237 (2024).","journal-title":"Endocrine"},{"key":"4334_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103346","volume":"61","author":"I Pe\u0107in","year":"2022","unstructured":"I. Pe\u0107in, D. Leskovar, M. \u0160abi\u0107, D. Perica, N. \u0160u\u0107ur, A. Godan Hauptman, I. Mer\u0107ep, F. Borove\u010dki, V. Premu\u017ei\u0107, B. Jelakovi\u0107, \u017d Reiner, Prophylactic therapeutic plasma exchange in pregnant woman with familial chylomicronemia syndrome - a case report. Transfus. Apher. Sci. 61, 103346 (2022).","journal-title":"Transfus. Apher. Sci."},{"key":"4334_CR21","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1111\/trf.15532","volume":"59","author":"E Fitts","year":"2019","unstructured":"E. Fitts, P.D.K. Lee, S.G. Yates, Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemia. Transfusion 59, 3324\u20133328 (2019).","journal-title":"Transfusion"},{"key":"4334_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12020-015-0838-9","volume":"52","author":"A Tikka","year":"2016","unstructured":"A. Tikka, M. Jauhiainen, The role of ANGPTL3 in controlling lipoprotein metabolism. Endocrine 52, 187\u2013193 (2016).","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04334-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04334-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04334-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:23Z","timestamp":1758772823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04334-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04334-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Signed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}